2018 annual financial data
CytomX Therapeutics, Inc. 2018 Operating margin
CytomX Therapeutics, Inc. 2018 operating margin with verified reported values.
Direct answer
Operating margin was -130.88%.
Operating income was -77,874,000 USD and net income was -84,604,000 USD.
Operating cash flow was -75,521,000 USD.
Get free CytomX Therapeutics, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 59,502,000 USD
- Operating income
- -77,874,000 USD
- Net income
- -84,604,000 USD
- Operating cash flow
- -75,521,000 USD